{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:05:59Z","timestamp":1790802359943,"version":"4.1.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The K1 gene of Kaposi sarcoma\u2013associated herpesvirus (KSHV) encodes a transmembrane glycoprotein bearing a functional immunoreceptor tyrosine-based activation motif (ITAM). Previously, we reported that the K1 protein induced plasmablastic lymphomas in K1 transgenic mice, and that these lymphomas showed enhanced Lyn kinase activity. Here, we report that systemic administration of the nuclear factor kappa B (NF-\u03baB) inhibitor Bay 11-7085 or an anti\u2013vascular endothelial growth factor (VEGF) antibody significantly reduced K1 lymphoma growth in nude mice. Furthermore, in KVL-1 cells, a cell line derived from a K1 lymphoma, inhibition of Lyn kinase activity by the Src kinase inhibitor PP2 decreased VEGF induction, NF-\u03baB activity, and the cell proliferation index by 50% to 75%. In contrast, human B-cell lymphoma BJAB cells expressing K1, but not the ITAM sequence\u2013deleted mutant K1, showed a marked increase in Lyn kinase activity with concomitant VEGF induction and NF-\u03baB activation, indicating that ITAM sequences were required for the Lyn kinase\u2013mediated activation of these factors. Our results suggested that K1-mediated constitutive Lyn kinase activation in K1 lymphoma cells is crucial for the production of VEGF and NF-\u03baB activation, both strongly implicated in the development of KSHV-induced lymphoproliferative disorders.<\/jats:p>","DOI":"10.1182\/blood-2004-07-2781","type":"journal-article","created":{"date-parts":[[2005,1,22]],"date-time":"2005-01-22T01:46:06Z","timestamp":1106358366000},"page":"3987-3994","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Activation of Src kinase Lyn by the Kaposi sarcoma\u2013associated herpesvirus K1 protein: implications for lymphomagenesis"],"prefix":"10.1182","volume":"105","author":[{"given":"Om","family":"Prakash","sequence":"first","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Rama","family":"Swamy","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiochang","family":"Peng","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ya","family":"Tang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Larson","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Craig","family":"Cohen","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Gill","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gist","family":"Farr","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suizhao","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Samaniego","sequence":"additional","affiliation":[{"name":"From the Laboratory of Molecular Oncology and the Department of Pathology, Ochsner Clinic Foundation, New Orleans, LA; the Department of Lymphoma\/Myeloma and Immunology, The University of Texas M. D. Anderson Cancer Center, and the Program in Gene Therapy and Virology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218163588300_REF1","doi-asserted-by":"crossref","unstructured":"Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266: 1865-1869.","DOI":"10.1126\/science.7997879"},{"key":"2020021218163588300_REF2","doi-asserted-by":"crossref","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med.1995;332: 1186-1191.","DOI":"10.1056\/NEJM199505043321802"},{"key":"2020021218163588300_","doi-asserted-by":"crossref","unstructured":"Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86: 1276-1280.","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276"},{"key":"2020021218163588300_REF4","doi-asserted-by":"crossref","unstructured":"Boshoff C, Weiss RA. Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res.1998;75: 57-86.","DOI":"10.1016\/S0065-230X(08)60739-3"},{"key":"2020021218163588300_REF5","doi-asserted-by":"crossref","unstructured":"Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev.2003;67: 175-212.","DOI":"10.1128\/MMBR.67.2.175-212.2003"},{"key":"2020021218163588300_REF6","doi-asserted-by":"crossref","unstructured":"Lee H, Guo J, Li M, et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol.1998;18: 5219-5228.","DOI":"10.1128\/MCB.18.9.5219"},{"key":"2020021218163588300_REF7","doi-asserted-by":"crossref","unstructured":"Cambier JC. Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol.1995;155: 3281-3285.","DOI":"10.4049\/jimmunol.155.7.3281"},{"key":"2020021218163588300_REF8","doi-asserted-by":"crossref","unstructured":"Lagunoff M, Lukac DM, Ganem D. Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol.2001;75: 5891-5898.","DOI":"10.1128\/JVI.75.13.5891-5898.2001"},{"key":"2020021218163588300_REF9","doi-asserted-by":"crossref","unstructured":"Samaniego F, Pati S, Karp JE, Prakash O, Bose D. Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J Natl Cancer Inst Monogr.2001;28: 15-23.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024252"},{"key":"2020021218163588300_REF10","doi-asserted-by":"crossref","unstructured":"Tomlinson CC, Damania B. The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol.2004;78: 1918-1927.","DOI":"10.1128\/JVI.78.4.1918-1927.2004"},{"key":"2020021218163588300_REF11","unstructured":"Wang S, Young D, Samaniego F. Expression of human herpesvirus 8 (HHV-8) K1 suppresses apoptosis of BJAB cell induced by anti-fas antibody [abstract 750]. Proc Am Cancer Res.2002; 43: 151."},{"key":"2020021218163588300_REF12","doi-asserted-by":"crossref","unstructured":"Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med.1998;4: 435-440.","DOI":"10.1038\/nm0498-435"},{"key":"2020021218163588300_REF13","doi-asserted-by":"crossref","unstructured":"Lagunoff M, Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology. 1997; 236: 147-154.","DOI":"10.1006\/viro.1997.8713"},{"key":"2020021218163588300_REF14","doi-asserted-by":"crossref","unstructured":"Lee BS, Connole M, Tang Z, Harris NL, Jung JU. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J Virol.2003;77: 8072-8086.","DOI":"10.1128\/JVI.77.14.8072-8086.2003"},{"key":"2020021218163588300_REF15","doi-asserted-by":"crossref","unstructured":"Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor\/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A.1997;94: 979-984.","DOI":"10.1073\/pnas.94.3.979"},{"key":"2020021218163588300_REF16","doi-asserted-by":"crossref","unstructured":"Aoki Y, Tosato G. Role of vascular endothelial growth factor\/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood. 1999;94: 4247-4254.","DOI":"10.1182\/blood.V94.12.4247"},{"key":"2020021218163588300_","doi-asserted-by":"crossref","unstructured":"Liu C, Okruzhnov Y, Li H, Nicholas J. Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J Virol.2001;75: 10933-10940.","DOI":"10.1128\/JVI.75.22.10933-10940.2001"},{"key":"2020021218163588300_REF18","doi-asserted-by":"crossref","unstructured":"Nishi J, Arimura K, Utsunomiya A, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. Br J Haematol.1999; 104: 482-485.","DOI":"10.1046\/j.1365-2141.1999.01208.x"},{"key":"2020021218163588300_REF19","doi-asserted-by":"crossref","unstructured":"Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma. 2000;38: 387-394.","DOI":"10.3109\/10428190009087030"},{"key":"2020021218163588300_","unstructured":"Samaniego F, Young D, Grimes C, et al. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts. Cell Growth Differ.2002;13: 387-395."},{"key":"2020021218163588300_REF21","doi-asserted-by":"crossref","unstructured":"Cannon M, Philpott NJ, Cesarman E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol.2003;77: 57-67.","DOI":"10.1128\/JVI.77.1.57-67.2003"},{"key":"2020021218163588300_REF22","doi-asserted-by":"crossref","unstructured":"Prakash O, Tang ZY, Peng X, et al. Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J Natl Cancer Inst.2002;94: 926-935.","DOI":"10.1093\/jnci\/94.12.926"},{"key":"2020021218163588300_REF23","doi-asserted-by":"crossref","unstructured":"Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL. Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem.1994;269: 29697-29703.","DOI":"10.1016\/S0021-9258(18)43936-1"},{"key":"2020021218163588300_REF24","doi-asserted-by":"crossref","unstructured":"Brown KA, Aakre ME, Gorska AE, et al. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res.2004;6: R215-231.","DOI":"10.1186\/bcr778"},{"key":"2020021218163588300_REF25","doi-asserted-by":"crossref","unstructured":"Prakash O, Tang ZY, Zhou P, et al. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line. Alcohol Clin Exp Res.2002;26: 295-302.","DOI":"10.1111\/j.1530-0277.2002.tb02538.x"},{"key":"2020021218163588300_REF26","doi-asserted-by":"crossref","unstructured":"Pati S, Cavrois M, Guo HG, et al. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol.2001;75: 8660-8673.","DOI":"10.1128\/JVI.75.18.8660-8673.2001"},{"key":"2020021218163588300_REF27","unstructured":"Shi Q, Le X, Abbruzzese JL, et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res.2001;61: 4143-4154."},{"key":"2020021218163588300_REF28","doi-asserted-by":"crossref","unstructured":"Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood. 2000;96: 2537-2542.","DOI":"10.1182\/blood.V96.7.2537"},{"key":"2020021218163588300_REF29","doi-asserted-by":"crossref","unstructured":"Pierce J, Schoenleber R, Jesmok G, et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem.1997;272: 21096-21103.","DOI":"10.1074\/jbc.272.34.21096"},{"key":"2020021218163588300_REF30","doi-asserted-by":"crossref","unstructured":"Lagunoff M, Majeti R, Weiss A, Ganem D. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A.1999;96: 5704-5709.","DOI":"10.1073\/pnas.96.10.5704"},{"key":"2020021218163588300_REF31","doi-asserted-by":"crossref","unstructured":"Bowser BS, DeWire SM, Damania B. Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol.2002;76: 12574-12583.","DOI":"10.1128\/JVI.76.24.12574-12583.2002"},{"key":"2020021218163588300_REF32","doi-asserted-by":"crossref","unstructured":"Yi TL, Bolen JB, Ihle JN. Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus. Mol Cell Biol.1991;11: 2391-2398.","DOI":"10.1128\/MCB.11.5.2391"},{"key":"2020021218163588300_REF33","doi-asserted-by":"crossref","unstructured":"Yamanashi Y, Mori S, Yoshida M, et al. Selective expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I. Proc Natl Acad Sci U S A.1989;86: 6538-6542.","DOI":"10.1073\/pnas.86.17.6538"},{"key":"2020021218163588300_REF34","doi-asserted-by":"crossref","unstructured":"Yamanashi Y, Kakiuchi T, Mizuguchi J, Yamamoto T, Toyoshima K. Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science. 1991;251: 192-194.","DOI":"10.1126\/science.1702903"},{"key":"2020021218163588300_REF35","doi-asserted-by":"crossref","unstructured":"Burg DL, Furlong MT, Harrison ML, Geahlen RL. Interactions of Lyn with the antigen receptor during B cell activation. J Biol Chem.1994;269: 28136-28142.","DOI":"10.1016\/S0021-9258(18)46905-0"},{"key":"2020021218163588300_REF36","doi-asserted-by":"crossref","unstructured":"Wei S, Liu JH, Epling-Burnette PK, et al. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J Immunol.1996;157: 5155-5162.","DOI":"10.4049\/jimmunol.157.11.5155"},{"key":"2020021218163588300_","doi-asserted-by":"crossref","unstructured":"Katagiri K, Yokoyama KK, Yamamoto T, Omura S, Irie S, Katagiri T. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J Biol Chem.1996;271: 11557-11562.","DOI":"10.1074\/jbc.271.19.11557"},{"key":"2020021218163588300_","unstructured":"Bates RC, Edwards NS, Burns GF, Fisher DE. A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase\/Akt in colon carcinoma cells. Cancer Res.2001;61: 5275-5283."},{"key":"2020021218163588300_REF39","doi-asserted-by":"crossref","unstructured":"Grishin AV, Azhipa O, Semenov I, Corey SJ. Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis. Proc Natl Acad Sci U S A.2001;98: 10172-10177.","DOI":"10.1073\/pnas.191130798"},{"key":"2020021218163588300_REF40","doi-asserted-by":"crossref","unstructured":"O'Laughlin-Bunner B, Radosevic N, Taylor ML, et al. Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood. 2001;98: 343-350.","DOI":"10.1182\/blood.V98.2.343"},{"key":"2020021218163588300_","doi-asserted-by":"crossref","unstructured":"Ishikawa H, Tsuyama N, Abroun S, et al. Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6. Blood. 2002;99: 2172-2178.","DOI":"10.1182\/blood.V99.6.2172"},{"key":"2020021218163588300_REF42","doi-asserted-by":"crossref","unstructured":"Hsueh RC, Scheuermann RH. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv Immunol.2000;75: 283-316.","DOI":"10.1016\/S0065-2776(00)75007-3"},{"key":"2020021218163588300_REF43","doi-asserted-by":"crossref","unstructured":"Donato NJ, Wu JY, Stapley J, et al. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood. 2003;101: 690-698.","DOI":"10.1182\/blood.V101.2.690"},{"key":"2020021218163588300_REF44","doi-asserted-by":"crossref","unstructured":"Geahlen RL, McLaughlin JL. Piceatannol (3,4,3\u2032,5\u2032-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun.1989;165: 241-245.","DOI":"10.1016\/0006-291X(89)91060-7"},{"key":"2020021218163588300_REF45","doi-asserted-by":"crossref","unstructured":"Foss HD, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol.1997;183: 44-50.","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<44::AID-PATH1103>3.0.CO;2-I"},{"key":"2020021218163588300_REF46","doi-asserted-by":"crossref","unstructured":"Liou HC, Sha WC, Scott ML, Baltimore D. Sequential induction of NF-kappa B\/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol.1994;14: 5349-5359.","DOI":"10.1128\/MCB.14.8.5349"},{"key":"2020021218163588300_","doi-asserted-by":"crossref","unstructured":"Bendall HH, Sikes ML, Ballard DW, Oltz EM. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. Mol Immunol.1999;36: 187-195.","DOI":"10.1016\/S0161-5890(99)00031-0"},{"key":"2020021218163588300_REF48","doi-asserted-by":"crossref","unstructured":"Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci U S A.2000;97: 6055-6060.","DOI":"10.1073\/pnas.100119497"},{"key":"2020021218163588300_REF49","doi-asserted-by":"crossref","unstructured":"Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest.1997;100: 2961-2969.","DOI":"10.1172\/JCI119849"},{"key":"2020021218163588300_REF50","doi-asserted-by":"crossref","unstructured":"Downward J. Mechanisms and consequences of activation of protein kinase B\/Akt. Curr Opin Cell Biol.1998;10: 262-267.","DOI":"10.1016\/S0955-0674(98)80149-X"},{"key":"2020021218163588300_REF51","doi-asserted-by":"crossref","unstructured":"Pogue SL, Kurosaki T, Bolen J, Herbst R. B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase. J Immunol.2000;165: 1300-1306.","DOI":"10.4049\/jimmunol.165.3.1300"},{"key":"2020021218163588300_REF52","doi-asserted-by":"crossref","unstructured":"Gold MR, Scheid MP, Santos L, et al. The B cell antigen receptor activates the Akt (protein kinase B)\/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J Immunol.1999;163: 1894-1905.","DOI":"10.4049\/jimmunol.163.4.1894"},{"key":"2020021218163588300_REF53","doi-asserted-by":"crossref","unstructured":"Pati S, Foulke JS Jr, Barabitskaya O, et al. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol.2003;77: 5759-5773.","DOI":"10.1128\/JVI.77.10.5759-5773.2003"},{"key":"2020021218163588300_REF54","unstructured":"Jenner RG, Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta.2002;1602: 1-22."},{"key":"2020021218163588300_REF55","doi-asserted-by":"crossref","unstructured":"Aoki Y, Yarchoan R, Wyvill K, Okamoto S, Little RF, Tosato G. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood. 2001;97: 2173-2176.","DOI":"10.1182\/blood.V97.7.2173"},{"key":"2020021218163588300_REF56","doi-asserted-by":"crossref","unstructured":"Bellamy WT. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Semin Oncol.2001;28: 551-559.","DOI":"10.1016\/S0093-7754(01)90023-5"},{"key":"2020021218163588300_REF57","doi-asserted-by":"crossref","unstructured":"Emilie D, Coumbaras J, Raphael M, et al. Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood. 1992;80: 498-504.","DOI":"10.1182\/blood.V80.2.498.498"},{"key":"2020021218163588300_REF58","doi-asserted-by":"crossref","unstructured":"Nicholas J. Human herpesvirus-8-encoded signalling ligands and receptors. J Biomed Sci.2003;10: 475-489.","DOI":"10.1007\/BF02256109"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/10\/3987\/1708344\/zh801005003987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/10\/3987\/1708344\/zh801005003987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T19:26:00Z","timestamp":1682969160000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/10\/3987\/19906\/Activation-of-Src-kinase-Lyn-by-the-Kaposi"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,15]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-07-2781","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,15]]}}}